Back to search

Article

The structure of the humanised A33 Fab C226S variant, an immunotherapy candidate for colorectal cancer

2022-06-21

Abstract excerpt

Colorectal cancer (CRC) causes the second highest cancer-related deaths worldwide. The human A33 antigen is a validated immunotherapy target, which is homogeneously expressed in 95% cases of primary and metastatic colorectal cancers. In this article, we report the structure of a humanised antigen-binding fragment A33 (A33 Fab), a therapeutic antibody candidate, in two different crystal forms. Insights into the str...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f7a68bd4-f95f-5c4a-8580-3bc8daca7c0a
DOI
10.1101/2022.06.21.497004
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The structure of the humanised A33 Fab C226S variant, an immunotherapy candidate for colorectal cancerDOI 10.1101/2022.06.21.497004
Select a neighboring publication to make it the new centre.